Norges Bank’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $344K | Buy |
+63,454
| New | +$243K | ﹤0.01% | 1609 |
|
|
2026
Q1 | – | Sell |
-63,454
| Closed | -$254K | – | 470 |
|
|
2025
Q4 | $254K | Buy |
+63,454
| New | +$353K | ﹤0.01% | 1563 |
|
|
2025
Q3 | – | Sell |
-179,062
| Closed | -$2.02M | – | 529 |
|
|
2025
Q2 | $2.02M | Sell |
179,062
-497,397
| -74% | -$4.57M | ﹤0.01% | 1438 |
|
|
2025
Q1 | $6.41M | Sell |
676,459
-436,375
| -39% | -$4.41M | ﹤0.01% | 1338 |
|
|
2024
Q4 | $12.5M | Sell |
1,112,834
-234,422
| -17% | -$4.12M | ﹤0.01% | 1311 |
|
|
2024
Q3 | $38.1M | Buy |
1,347,256
+142,203
| +12% | +$3.67M | 0.01% | 1066 |
|
|
2024
Q2 | $23M | Sell |
1,205,053
-190,194
| -14% | -$4.86M | ﹤0.01% | 1183 |
|
|
2024
Q1 | $45.8M | Buy |
1,395,247
+70,426
| +5% | +$2.25M | 0.01% | 979 |
|
|
2023
Q4 | $43.8M | Buy |
1,324,821
+447,723
| +51% | +$12.7M | 0.01% | 963 |
|
|
2023
Q3 | $23.9M | Sell |
877,098
-342,822
| -28% | -$9.53M | ﹤0.01% | 1159 |
|
|
2023
Q2 | $37M | Buy |
1,219,920
+371,587
| +44% | +$12M | 0.01% | 1003 |
|
|
2023
Q1 | $27.5M | Buy |
848,333
+2,775
| +0.3% | +$87.8K | 0.01% | 1124 |
|
|
2022
Q4 | $23.7M | Buy |
845,558
+38,599
| +5% | +$1.11M | 0.01% | 1175 |
|
|
2022
Q3 | $29M | Buy |
806,959
+26,422
| +3% | +$931K | 0.01% | 1024 |
|
|
2022
Q2 | $24M | Sell |
780,537
-27,538
| -3% | -$802K | 0.01% | 1155 |
|
|
2022
Q1 | $26.1M | Sell |
808,075
-82,761
| -9% | -$2.17M | 0.01% | 1245 |
|
|
2021
Q4 | $24.6M | Buy |
890,836
+301,669
| +51% | +$8.65M | 0.01% | 1361 |
|
|
2021
Q3 | $18.3M | Sell |
589,167
-65,906
| -10% | -$1.58M | ﹤0.01% | 1537 |
|
|
2021
Q2 | $13.8M | Buy |
655,073
+372,287
| +132% | +$7.46M | ﹤0.01% | 1680 |
|
|
2021
Q1 | $5.71M | Sell |
282,786
-162,922
| -37% | -$3.1M | ﹤0.01% | 1888 |
|
|
2020
Q4 | $7.14M | Buy |
445,708
+89,683
| +25% | +$1.19M | ﹤0.01% | 1826 |
|
|
2020
Q3 | $4.42M | Sell |
356,025
-298,957
| -46% | -$3.52M | ﹤0.01% | 1883 |
|
|
2020
Q2 | $4.66M | Buy |
654,982
+451,472
| +222% | +$3.02M | ﹤0.01% | 1873 |
|
|
2020
Q1 | $1.1M | Hold |
203,510
| – | – | ﹤0.01% | 1973 |
|
|
2019
Q4 | $1.84M | Hold |
203,510
| – | – | ﹤0.01% | 1988 |
|
|
2019
Q3 | $1.46M | Sell |
203,510
-97,824
| -32% | -$702K | ﹤0.01% | 2012 |
|
|
2019
Q2 | $2.4M | Hold |
301,334
| – | – | ﹤0.01% | 1987 |
|
|
2019
Q1 | $3.79M | Hold |
301,334
| – | – | ﹤0.01% | 1966 |
|
|
2018
Q4 | $6.01M | Buy |
301,334
+118,295
| +65% | +$2.74M | ﹤0.01% | 1891 |
|
|
2018
Q3 | $5.2M | Buy |
183,039
+107,791
| +143% | +$2.57M | ﹤0.01% | 1963 |
|
|
2018
Q2 | $1.58M | Buy |
75,248
+75,240
| +940,500% | +$1.42M | ﹤0.01% | 2044 |
|
|
2018
Q1 | $1K | Buy |
+8
| New | +$115 | ﹤0.01% | 2133 |
|
|
2017
Q3 | – | Sell |
-400,000
| Closed | -$10.1M | – | 2135 |
|
|
2017
Q2 | $10.1M | Buy |
+400,000
| New | +$9.62M | ﹤0.01% | 1736 |
|
|
2016
Q2 | – | Sell |
-40,000
| Closed | -$422K | – | 2179 |
|
|
2016
Q1 | $422K | Hold |
40,000
| – | – | ﹤0.01% | 2139 |
|
|
2015
Q4 | $484K | Hold |
40,000
| – | – | ﹤0.01% | 2170 |
|
|
2015
Q3 | $638K | Hold |
40,000
| – | – | ﹤0.01% | 2165 |
|
|
2015
Q2 | $780K | Buy |
+40,000
| New | +$746K | ﹤0.01% | 2149 |
|
Other funds holding EVH
CCM
RF
EC
Norges Bank's EVH Position: Q2 2026 in Review
Norges Bank opened a new position in Evolent Health (EVH) in Q2 2026: 63,454 shares worth $344K. The stake represents ﹤0.01% of the portfolio and ranks #1609 among its holdings. This is a return to the name: Norges Bank previously reported a position in EVH as recently as Q4 2025.
Norges Bank first reported a position in EVH in Q2 2015 and has held it in 37 quarters since. The position peaked at $45.8M in Q1 2024. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.
- Norges Bank held 63,454 shares of Evolent Health worth $344K as of Q2 2026.
- Evolent Health was a new Norges Bank position in Q2 2026.
- Evolent Health made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1609 holding.
- Norges Bank first reported a position in Evolent Health in Q2 2015 and has held it in 37 quarters since.
- Norges Bank's Evolent Health position peaked at $45.8M in Q1 2024.
- 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.
Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.